Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: A Phase II, Open-Label, Extension Study to Assess the Safety and Efficacy of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)
Brief Summary: This is an open-label, extension study of NS-065/NCNP-01 administered intravenously once weekly for an additional 24 weeks to boys with DMD who complete Study NS-065/NCNP-01-201.